Ocular Therapeutix (OCUL) Gross Margin (2014 - 2026)
Ocular Therapeutix's (OCUL) quarterly Gross Margin came in at 87.68% in Q1 2026, down 53.0% year-on-year from 186.55% in Q1 2025, and little changed quarter-over-quarter from 87.97% in Q4 2025.
Ocular Therapeutix (OCUL) Gross Margin (2014 - 2026) Analysis & Trends
Ocular Therapeutix's Gross Margin history runs 13 years deep, the most recent figure standing at 87.68% for Q1 2026.
- On a quarterly basis, Gross Margin fell 53.0% year-over-year to 87.68% in Q1 2026; TTM through Mar 2026 was 87.24%, a 344.0% decrease from a year earlier, with the FY2025 full-year figure at 87.35%, down 383.0% from the prior year.
- Gross Margin held at 87.68% in Q1 2026 per OCUL's latest filing, from 87.97% in the prior quarter.
- Across five years, Gross Margin topped out at 92.81% in Q4 2022 and bottomed at 85.56% in Q2 2025.
- The 5-year median for Gross Margin is 90.64% (2023), against an average of 90.01%.
- Across the five-year window, Gross Margin soared 229 bps in 2022 and plunged 527 bps in 2025, its largest moves.
- Year by year, Gross Margin stood at 92.81% in 2022, then slipped by 2 bps to 90.64% in 2023, then increased by 2 bps to 92.8% in 2024, then slipped by 5 bps to 87.97% in 2025, then declined by 0 bps to 87.68% in 2026.
- Per Business Quant, the three latest OCUL Gross Margin figures stand at 87.68% (Q1 2026), 87.97% (Q4 2025), and 87.8% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 88.95% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 90.68% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ocular Therapeutix | 1.91 Bn | 1.91 Bn | 9.46 Mn | 87.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.68% |
| Dec 31, 2025 | 87.97% |
| Sep 30, 2025 | 87.80% |
| Jun 30, 2025 | 85.56% |
| Mar 31, 2025 | 88.20% |
| Dec 31, 2024 | 92.80% |
| Sep 30, 2024 | 89.88% |
| Jun 30, 2024 | 90.82% |
| Mar 31, 2024 | 91.02% |
| Dec 31, 2023 | 90.64% |
| Sep 30, 2023 | 90.87% |
| Jun 30, 2023 | 91.41% |
| Mar 31, 2023 | 90.92% |
| Dec 31, 2022 | 92.81% |
| Sep 30, 2022 | 91.03% |
| Jun 30, 2022 | 90.58% |
| Mar 31, 2022 | 90.14% |
| Dec 31, 2021 | 91.00% |
| Sep 30, 2021 | 89.22% |
| Jun 30, 2021 | 90.65% |